Ecliptasaponin A protects heart against acute ischemia-induced myocardial injury by inhibition of the HMGB1/TLR4/NF-κB pathway
- 22 July 2024
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 335, 118612
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82000257)
- Natural Science Foundation of Jiangsu Province (BK20231244)
- Jiangsu Commission of Health
This publication has 42 references indexed in Scilit:
- Glycyrrhizic acid ameliorates myocardial ischemia-reperfusion injury in rats through inhibiting endoplasmic reticulum stressEuropean Journal of Pharmacology, 2021
- HMGB1 as a therapeutic target in diseaseJournal of Cellular Physiology, 2020
- Structural characteristics, bioavailability and cardioprotective potential of saponinsIntegrative Medicine Research, 2018
- Expert Review on the Prognostic Role of Echocardiography after Acute Myocardial InfarctionJournal of the American Society of Echocardiography, 2017
- Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial InfarctionJACC, 2016
- Eclipta prostrata L. phytochemicals: Isolation, structure elucidation, and their antitumor activityFood and Chemical Toxicology, 2012
- Antiinflammatory Constituents from Eclipta prostrata using RAW264.7 Macrophage CellsPhytotherapy Research, 2011
- Acute myocardial infarction and heart failure: Role of apoptosisThe International Journal of Biochemistry & Cell Biology, 2006
- HMGB1: guiding immunity from withinTrends in Immunology, 2005
- Structural Basis for the Proinflammatory Cytokine Activity of High Mobility Group Box 1Molecular Medicine, 2003